NO20003104D0 - KaliumkanalÕpnere - Google Patents

KaliumkanalÕpnere

Info

Publication number
NO20003104D0
NO20003104D0 NO20003104A NO20003104A NO20003104D0 NO 20003104 D0 NO20003104 D0 NO 20003104D0 NO 20003104 A NO20003104 A NO 20003104A NO 20003104 A NO20003104 A NO 20003104A NO 20003104 D0 NO20003104 D0 NO 20003104D0
Authority
NO
Norway
Prior art keywords
opening
potassium channel
kaliumkanalõpnere
potassium
ameliorated
Prior art date
Application number
NO20003104A
Other languages
English (en)
Other versions
NO317099B1 (no
NO20003104L (no
Inventor
William A Carroll
Mark W Holladay
James P Sullivan
Irene Drizin
Henry Q Zhang
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/206,055 external-priority patent/US6265417B1/en
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of NO20003104D0 publication Critical patent/NO20003104D0/no
Publication of NO20003104L publication Critical patent/NO20003104L/no
Publication of NO317099B1 publication Critical patent/NO317099B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/29Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups
    • C07C45/298Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups with manganese derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nutrition Science (AREA)
  • Urology & Nephrology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Glass Compositions (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
  • Quinoline Compounds (AREA)
  • Feeding And Controlling Fuel (AREA)
  • Pyridine Compounds (AREA)
  • Ladders (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Toys (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogen, Water And Hydrids (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
NO20003104A 1997-12-18 2000-06-16 Kaliumkanalapnere NO317099B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US99339297A 1997-12-18 1997-12-18
US09/206,055 US6265417B1 (en) 1997-12-18 1998-12-04 Potassium channel openers
PCT/US1998/026780 WO1999031059A1 (en) 1997-12-18 1998-12-16 Potassium channel openers

Publications (3)

Publication Number Publication Date
NO20003104D0 true NO20003104D0 (no) 2000-06-16
NO20003104L NO20003104L (no) 2000-08-17
NO317099B1 NO317099B1 (no) 2004-08-09

Family

ID=26901004

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003104A NO317099B1 (no) 1997-12-18 2000-06-16 Kaliumkanalapnere

Country Status (22)

Country Link
US (1) US20010036950A1 (no)
EP (1) EP1040097B1 (no)
JP (1) JP2002508354A (no)
CN (1) CN1158259C (no)
AT (1) ATE264303T1 (no)
AU (1) AU756505B2 (no)
BG (1) BG64309B1 (no)
BR (1) BR9813634A (no)
CA (1) CA2314948A1 (no)
DE (1) DE69823227T2 (no)
DK (1) DK1040097T3 (no)
ES (1) ES2222000T3 (no)
HK (1) HK1032583A1 (no)
HU (1) HUP0100112A3 (no)
IL (1) IL135985A0 (no)
NO (1) NO317099B1 (no)
NZ (1) NZ504371A (no)
PL (1) PL341298A1 (no)
PT (1) PT1040097E (no)
SK (1) SK8732000A3 (no)
TR (1) TR200001715T2 (no)
WO (1) WO1999031059A1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6593335B1 (en) * 1997-12-18 2003-07-15 Abbott Laboratories Potassium channel openers
US6265417B1 (en) 1997-12-18 2001-07-24 Abbott Laboratories Potassium channel openers
US6191140B1 (en) 1998-10-28 2001-02-20 Abbott Laboratories Pyrano, piperidino, and thiopyrano compounds and methods of use
CA2348165A1 (en) * 1998-10-28 2000-05-04 Abbott Laboratories Dihydropyridine compounds and methods of use
US6642222B2 (en) * 1998-10-28 2003-11-04 Abbott Laboratories Pyrano, piperidino, and thiopyrano compounds and methods of use
US6518279B2 (en) 1999-03-04 2003-02-11 Abbott Laboratories Cyclopentanone dihydropyridine compounds useful as potassium channel openers
KR20030026979A (ko) * 2000-07-18 2003-04-03 야마노우치세이야쿠 가부시키가이샤 디시아노피리딘 유도체를 포함하는 의약
CA2476824A1 (en) * 2002-02-19 2003-08-28 Abbott Laboratories Iodination of 4-fluoro-benzaldehyde

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2658804A1 (de) * 1976-12-24 1978-07-06 Bayer Ag Kreislaufbeeinflussende mittel
DE2747513A1 (de) * 1977-10-22 1979-05-03 Bayer Ag Dihydropyridine mit schwefelhaltigen estergruppierungen
US4777167A (en) * 1986-04-09 1988-10-11 Ortho Pharmaceutical Corporation Pharmaceutically useful substituted thiacycloalkeno [3,2-b]pyridines, compositions and method of use
US4879384A (en) * 1988-06-15 1989-11-07 Ortho Pharmaceutical Corporation Preparation of thiocycloalkno [3,2-b] pyridines
US5075440A (en) * 1990-05-03 1991-12-24 Ortho Pharmaceutical Corporation Novel pyrido[2,3-f](1,4)thiazepines and pyrido[3,2-b](1,5)benzothiazepines
JP3285963B2 (ja) * 1991-10-21 2002-05-27 インペリアル・ケミカル・インダストリーズ・ピーエルシー 治療剤
GB9318935D0 (en) * 1992-10-20 1993-10-27 Zeneca Ltd Heterocyclic derivatives
DE4424678A1 (de) * 1994-07-13 1996-01-18 Bayer Ag Dioxo-thiopyrano-pyridin-carbonsäure-derivate

Also Published As

Publication number Publication date
EP1040097B1 (en) 2004-04-14
DE69823227T2 (de) 2005-03-10
IL135985A0 (en) 2001-05-20
WO1999031059A1 (en) 1999-06-24
EP1040097A1 (en) 2000-10-04
HK1032583A1 (en) 2001-07-27
BG104594A (en) 2001-03-30
ES2222000T3 (es) 2005-01-16
CN1282321A (zh) 2001-01-31
TR200001715T2 (tr) 2000-12-21
BR9813634A (pt) 2000-10-17
PL341298A1 (en) 2001-04-09
DK1040097T3 (da) 2004-08-02
CN1158259C (zh) 2004-07-21
AU756505B2 (en) 2003-01-16
BG64309B1 (bg) 2004-09-30
ATE264303T1 (de) 2004-04-15
SK8732000A3 (en) 2000-11-07
JP2002508354A (ja) 2002-03-19
NO317099B1 (no) 2004-08-09
HUP0100112A3 (en) 2004-05-28
DE69823227D1 (de) 2004-05-19
PT1040097E (pt) 2004-08-31
CA2314948A1 (en) 1999-06-24
NO20003104L (no) 2000-08-17
US20010036950A1 (en) 2001-11-01
HUP0100112A2 (hu) 2001-08-28
AU1830799A (en) 1999-07-05
NZ504371A (en) 2002-02-01

Similar Documents

Publication Publication Date Title
DE60019121D1 (de) Kaliumkanäleöffner
AU2291097A (en) Novel phenanthridines substituted in the 6 position
MX9804588A (es) Uso de composiciones que comprenden blanqueador de halogeno para suavidad mejorada a la piel.
AU2169200A (en) Transistor with notched gate
ATE373642T1 (de) Kalium kanalaktivatoren
YU48698A (sh) Karboksamidni derivati pirolidina, piperidina i heksahidroazepina za lečenje oboljenja na bazi tromboze
ZA200005161B (en) Anti-inflammatory, antibacterial benzyl phenol agents.
PL325403A1 (en) Gate openable by rising same
DE69823227D1 (de) Kaliumkanalöffner
TR200003202T1 (tr) Potasyum kanalı açıcılar olarak faydalı siklopentanon dihidropiridin bileşikleri
MXPA03006969A (es) Abridores de canal de potasio.
TR199901386T2 (en) �midazopiridazinler.
MXPA03007071A (es) Aminaldionas como abridores del canal de potasio.
PT1259510E (pt) Agentes de abertura de canais de potassio de di-hidropirazolona triciclina e di-hidro-isoxazolona triciclina
WO2000024741A3 (en) Dihydropyridine compounds and their use as potassium channel openers
WO2000034285A3 (en) Substituted benzofuranoindoles and indenoindoles as novel potassium channel openers
MX9500228A (es) N-oxidos de 4-arilpiperazinas y 4-arilpiperidinas.
PT1104419E (pt) Derivados de azabicicloheptano substituidos no azoto sua preparacao e utilizacao
WO2001083480A3 (en) Dihydropyridine compounds and methods of use
TR200003084T2 (tr) Paroxetine askorbat
IL132504A0 (en) Methods for reducing fibrinogen
MX9709783A (es) Inmortalizacion y desinmortalizacion de celulas.